Severe cardiac dysrhythmia in patients using bromocriptine postpartum

American Journal of Therapeutics

Volumn 5, Issue 2, 1998, Pages 111-115

  Iffy, Leslie ^a,c   O'Donnell, James ^b   Correia, Joaquim ^a   Hopp, Laszlo ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c University of Medicine and Dentistry of New Jersey   (United States)

Author keywords

Ablactation; Bromocriptine; Cardiac arrest; Cardiac dysrhythmia

Indexed keywords

BROMOCRIPTINE MESILATE; PROLACTIN;

ADULT; ARTICLE; BRAIN EDEMA; BRAIN HEMORRHAGE; CASE REPORT; CONVULSION; DRUG SAFETY; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; LACTATION INHIBITION; PRIORITY JOURNAL; PUERPERAL PSYCHOSIS; PUERPERIUM; STROKE; VASOSPASM;

EID: 0031923296     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199803000-00010     Document Type: Article

References (19)

1. Prescribing information. Parlodel, Sandoz. Physicians' Desk Reference, 50th ed. Medical Economics, Montvale, NJ, 1996, pp. 2282-2284.
2. Standaert DG, Young AB: Treatment of central nervous system degenerative disorders. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed. (Eds. Hardman JG, Limbird LE), McGraw-Hill, New York, 1996, p. 511.
3. Ascoli M, Segaloff DL: Adenohypophyseal hormones and their hypothalamic releasing factors. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed. (Eds. Hardman JG, Limbird LE), McGraw-Hill, New York, 1996, p. 1372.
4. Dukes MNG: Drugs affecting autonomic functions or the extrapyramidal system. In: Meyler's Side Effects of Drugs, 13th ed. (Ed. Dukes MNG), Elsevier, Amsterdam, 1996, p. 359.
5. FDA Talk Paper. FDA Moves to End Use of Bromocriptine for Postpartum Breast Engorgement. Food and Drug Administration, US Department of Health and Human Services, Rockville, MD, August 17, 1994.
6. Iffy L, ten Hove W, Frisoli G: Acute myocardial infarction in the puerperium in patients receiving bromocriptine. Am J Obstet Gynecol 1986;155:371-372.
7. Ruch A, Duhring JL: Postpartum myocardial infarction in a patient receiving bromocriptine. Obstet Gynecol 1989;74:448-451.
8. Giudici MC, Artis AK, Webel RR, Alpert MA: Postpartum myocardial infarction in a patient receiving bromocriptine. Am Heart J 1989;118:614-616.
9. Iffy L, Hopp L: Megfigyeles a bromocriptine ablactatio es a myocardium infarctusa kapcsolatarol. Magy Noorv Lap (Budapest) 1990;53:135-137.
10. Eckman FM: Recurrent myocardial infarction in a postpartum patient receiving bromocriptine. Clin Cardiol 1992;15:781-783.
11. Larrazet F, Spaulding C, Lobreau HJ, Weber S, Guerin F: Possible bromocriptine induced myocardial infarction. Ann Intern Med 1993;118:199-200.
12. Hopp L, Weisse AB, Iffy L: Acute myocardial infarction in a healthy mother using bromocriptine for milk suppression. Can J Cardiol 1996;12:415-418.
13. Iffy L, McArdle JJ: The role of medico-legal reviews in medical research. Med Law 1996; 15:399-407.
14. Iffy L, ten Hove W, Hopp L, McArdle JJ: Cases of myocardial infarction postpartum during ablactation with bromocriptine. Isr J Obstet Gynecol 1995;6:74-80.
15. Iffy L, McArdle J, Hopp L: The pharmacologic background of hypertensive complications in the puerperium. In: Proceedings of the 28th International Congress on Pathophysiology of Pregnancy. Timisoara, May 22-25, 1996. CIC Edizioni Internazionali, Rome, 1996, pp. 296-301.
16. Iffy L: Lethal cardiovascular complications in patients receiving bromocriptine for ablactation. Med Law 1995; 14:99-104.
17. National High Blood Pressure Education Program Working Group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990;163:1689.
18. Bigger JT Jr: Cardiac arrhythmias. In: Cecil's Textbook of Medicine, 19th ed. (Eds. Wyngaarden JB, Smith LH Jr, Bennett JC), WB Saunders, Philadelphia, 1992, pp. 228-250.
19. Physicians' Desk Reference, 43rd ed. Medical Economics, Oradell, NJ, 1989, pp. 1888-1891.